| Carbohydrate Antigen CA125 |
Detects CA125, one of the tumor markers. Primarily used for
auxiliary diagnosis of malignant serous ovarian cancer and
epithelial ovarian cancer. It is also an indicator for monitoring
treatment efficacy after ovarian cancer surgery and chemotherapy.
It is recommended to combine with other tumor markers when used.
|
| Carbohydrate Antigen CA15-3 |
Detects CA15-3, one of the tumor markers. It has certain value
in the diagnosis of breast cancer and post-operative follow-up
monitoring. It is recommended to combine with other tumor markers
when used.
|
| Liver Function Test (11 items) |
Can indicate hepatobiliary system diseases: acute infectious
hepatitis, toxic hepatitis, fatty liver, cholangitis, cholecystitis,
drug-induced toxic hepatitis, alcoholic hepatitis, and jaundice.
|
| Rheumatoid Factor (RF) |
A laboratory test for rheumatic diseases; provides clues and
evidence for doctors to diagnose rheumatic conditions.
|
| Serum Low-Density Lipoprotein Cholesterol (LDL-C) |
Detects serum low-density lipoprotein. One of the common blood lipid
tests. Elevated LDL is a high-risk factor for coronary heart disease,
myocardial infarction, cerebrovascular disease, and atherosclerosis.
|
| Serum High-Density Lipoprotein Cholesterol (HDL-C) |
Detects serum high-density lipoprotein. One of the common blood lipid
tests. It has a protective effect on blood vessels. Low levels
increase the risk of atherosclerosis.
|
| Carcinoembryonic Antigen (CEA) Quantitative |
A broad-spectrum tumor marker that can indicate rectal cancer,
colon cancer, lung cancer, breast cancer, pancreatic cancer, etc.
|
| Alpha-Fetoprotein (AFP) Quantitative |
Can indicate primary liver cancer, germ cell tumors,
liver cirrhosis, etc.
|
| Fasting Blood Glucose |
Blood glucose (blood sugar) refers to the glucose in the blood.
It is of great value in assessing the body's glucose metabolism
status, diagnosing glucose metabolism disorders, and guiding
clinicians in formulating and adjusting treatment plans.
|
| Routine Urinalysis 1 |
Can indicate urinary system diseases: acute or chronic nephritis,
pyelonephritis, cystitis, urethritis, nephrotic syndrome, lupus
nephritis, hemoglobinuria, renal infarction, heavy metal salt or
drug-induced acute renal tubular necrosis, kidney or bladder tumors,
and no urine sugar, etc.
|
| Renal Function Test (3 items) |
Checks for kidney function impairment, such as uremia and
gouty kidney disease.
|
| Helicobacter pylori Antibody (Blood) |
Detects Helicobacter pylori antibodies. |
| Routine Blood Test (5-classification) |
One of the most commonly used initial screening tests in clinical
practice; provides clues and evidence for doctors to diagnose
blood system diseases.
|
| Serum Total Cholesterol |
Combined with other blood lipid tests to understand lipid metabolism.
|
| Serum Triglycerides |
Serum triglycerides — one of the most common blood lipid tests.
|
| Carbohydrate Antigen (CA19-9) |
Detects CA19-9, one of the tumor markers for gastrointestinal tumors.
It is recommended to combine with other tumor markers when used.
|
| Carbohydrate Antigen 242 (CA242) |
Detects CA242, one of the tumor markers. It is recommended to combine
with other tumor markers when used.
|
| Carbohydrate Antigen 50 (CA50) |
Detects CA50, one of the tumor markers. It is recommended to combine
with other tumor markers when used.
|
| Lactate Dehydrogenase (LDH) |
Increased LDH activity is mainly seen in myocardial infarction,
acute or chronic hepatitis, liver cancer, skeletal muscle diseases,
blood system diseases, pulmonary infarction, hypothyroidism,
kidney syndrome, and advanced malignant tumors.
|
| α-Hydroxybutyrate Dehydrogenase (α-HBDH) |
Elevated levels can be seen in myocardial infarction, active
rheumatic carditis, acute viral myocarditis, hemolytic anemia, etc.
|
| Creatine Kinase (CK) |
Elevated creatine kinase can be seen in myocardial infarction,
viral myocarditis, pericarditis, dermatomyositis, muscular
dystrophy, cerebral infarction, etc.
|
| Hepatitis B Two Half (HBsAg/Ab, HBeAg/Ab, HBcAb) |
Used to detect acute hepatitis B, chronic persistent hepatitis B,
chronic active hepatitis B, HBsAg carriers, and whether antibodies
appear after hepatitis B vaccination.
|
| Thyroid Function Test (3 items) |
Helps in the diagnosis of thyroid diseases or thyroid dysfunction;
it is currently the most commonly used endocrine test.
|
| Lipoprotein(a) |
Elevated Lipoprotein(a) is an independent risk indicator for
atherosclerosis.
|
| Cytokeratin 19 Fragment (CYFRA21-1) |
An important indicator for the differential diagnosis, treatment
monitoring, and prognosis judgment of non-small cell lung cancer
(NSCLC).
|
| Homocysteine (Hcy) |
A marker of cardiovascular disease risk; can be used as a risk
assessment factor to indicate the danger of disease occurrence.
|
| Glycated Hemoglobin (HbA1c) |
Reflects the average blood glucose level in the 1–2 months prior
to the examination; it is a key screening indicator for diabetes.
|
| Carbohydrate Antigen 72-4 (CA72-4) |
Detects CA72-4, which can serve as one of the tumor markers for
gastrointestinal tumors. It is recommended to combine with other
tumor markers when used.
|
| Neuron-specific Enolase (NSE) |
Detects neuron-specific enolase, one of the tumor markers.
It is recommended to combine with other tumor markers when used.
|
| Squamous Cell Carcinoma Antigen (SCC) |
A marker for squamous cell carcinoma, used for auxiliary diagnosis
and treatment monitoring of squamous cell cancers. It has relatively
high specificity; significantly elevated levels should raise
suspicion for squamous cell carcinoma.
|
| Antistreptolysin O (ASO) |
Commonly used as one of the laboratory tests for rheumatic diseases;
provides clues and evidence for doctors to diagnose rheumatic conditions.
|
| Malignant Tumor Specific Growth Factor |
A broad-spectrum tumor marker used for auxiliary diagnosis of tumors
and follow-up observation of high-risk populations.
|
| High-sensitivity C-Reactive Protein (hs-CRP) |
Important for the diagnosis and treatment monitoring of inflammation,
tissue injury, malignant tumors, and other diseases.
|
